|
⚲
|
| Keyboard |
| Mark Pruzanski | |
|---|---|
| Firm | |
| Address | c/o Abcuro, Inc 55 Chapel St Suite 200 Newton, MA 02458 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Abcuro Inc | 021-538655 | Director | 80.0 M of 200.0 M |
||
| Egenesis Inc | 021-506139 | Director | 25.4 M of 28.7 M |
||
| Egenesis Inc | 021-391712 | Director | 125.0 M of 125.0 M |
||
| Evelo Biosciences Inc | 021-278687 | Director | 50.0 M of 50.0 M |
||
| Intercept Pharmaceuticals Inc | 021-183201 | Executive Officer | 30.0 M of 50.0 M |
||